Clinical Trial Detail

NCT ID NCT03407976
Title Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors University of Utah
Indications

gastric adenocarcinoma

Advanced Solid Tumor

colorectal cancer

transitional cell carcinoma

gastroesophageal junction adenocarcinoma

Therapies

Apatinib + Pembrolizumab

Age Groups: adult senior

Additional content available in CKB BOOST